CNO FINANCIAL GROUP INC (CNO) Fundamental Analysis & Valuation

NYSE:CNO • US12621E1038

39.885 USD
-0.73 (-1.79%)
Last: Mar 11, 2026, 12:51 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CNO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CNO. CNO was compared to 149 industry peers in the Insurance industry. Both the profitability and financial health of CNO have multiple concerns. CNO is not valued too expensively and it also shows a decent growth rate. Finally CNO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. CNO Profitability Analysis

1.1 Basic Checks

  • CNO had positive earnings in the past year.
  • In the past year CNO had a positive cash flow from operations.
  • In the past 5 years CNO has always been profitable.
  • Each year in the past 5 years CNO had a positive operating cash flow.
CNO Yearly Net Income VS EBIT VS OCF VS FCFCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • CNO has a worse Return On Assets (0.57%) than 67.79% of its industry peers.
  • The Return On Equity of CNO (8.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.57%
ROE 8.4%
ROIC N/A
ROA(3y)0.83%
ROA(5y)1.19%
ROE(3y)12.67%
ROE(5y)16.9%
ROIC(3y)N/A
ROIC(5y)N/A
CNO Yearly ROA, ROE, ROICCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • CNO has a Profit Margin of 4.87%. This is in the lower half of the industry: CNO underperforms 66.44% of its industry peers.
  • In the last couple of years the Profit Margin of CNO has declined.
  • With a decent Operating Margin value of 14.55%, CNO is doing good in the industry, outperforming 63.09% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CNO has grown nicely.
Industry RankSector Rank
OM 14.55%
PM (TTM) 4.87%
GM N/A
OM growth 3Y-13.87%
OM growth 5Y3.77%
PM growth 3Y-34%
PM growth 5Y-8.49%
GM growth 3YN/A
GM growth 5YN/A
CNO Yearly Profit, Operating, Gross MarginsCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CNO Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CNO has less shares outstanding
  • The number of shares outstanding for CNO has been reduced compared to 5 years ago.
  • CNO has a better debt/assets ratio than last year.
CNO Yearly Shares OutstandingCNO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
CNO Yearly Total Debt VS Total AssetsCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • The Debt to FCF ratio of CNO is 6.00, which is a neutral value as it means it would take CNO, 6.00 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.00, CNO is doing worse than 64.43% of the companies in the same industry.
  • CNO has a Debt/Equity ratio of 1.54. This is a high value indicating a heavy dependency on external financing.
  • CNO's Debt to Equity ratio of 1.54 is on the low side compared to the rest of the industry. CNO is outperformed by 90.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF 6
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CNO Yearly LT Debt VS Equity VS FCFCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CNO Yearly Current Assets VS Current LiabilitesCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CNO Growth Analysis

3.1 Past

  • CNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.78%, which is quite good.
  • Measured over the past years, CNO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.80% on average per year.
  • Looking at the last year, CNO shows a small growth in Revenue. The Revenue has grown by 0.48% in the last year.
  • CNO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.44% yearly.
EPS 1Y (TTM)10.78%
EPS 3Y23.97%
EPS 5Y11.8%
EPS Q2Q%12.21%
Revenue 1Y (TTM)0.48%
Revenue growth 3Y8.15%
Revenue growth 5Y3.44%
Sales Q2Q%4.18%

3.2 Future

  • CNO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.54% yearly.
  • The Revenue is expected to grow by 4.06% on average over the next years.
EPS Next Y-0.12%
EPS Next 2Y4.88%
EPS Next 3Y7.63%
EPS Next 5Y9.54%
Revenue Next Year3.65%
Revenue Next 2Y3.48%
Revenue Next 3Y3.48%
Revenue Next 5Y4.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CNO Yearly Revenue VS EstimatesCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CNO Yearly EPS VS EstimatesCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. CNO Valuation Analysis

4.1 Price/Earnings Ratio

  • CNO is valuated reasonably with a Price/Earnings ratio of 9.02.
  • Based on the Price/Earnings ratio, CNO is valued a bit cheaper than the industry average as 64.43% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.25. CNO is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.03, the valuation of CNO can be described as very reasonable.
  • 60.40% of the companies in the same industry are more expensive than CNO, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CNO to the average of the S&P500 Index (24.39), we can say CNO is valued rather cheaply.
Industry RankSector Rank
PE 9.02
Fwd PE 9.03
CNO Price Earnings VS Forward Price EarningsCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 63.09% of the companies in the same industry are more expensive than CNO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.57
EV/EBITDA N/A
CNO Per share dataCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.76
EPS Next 2Y4.88%
EPS Next 3Y7.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

9

5. CNO Dividend Analysis

5.1 Amount

  • CNO has a Yearly Dividend Yield of 6.41%, which is a nice return.
  • CNO's Dividend Yield is rather good when compared to the industry average which is at 2.89. CNO pays more dividend than 83.89% of the companies in the same industry.
  • CNO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 6.41%

5.2 History

  • On average, the dividend of CNO grows each year by 7.36%, which is quite nice.
  • CNO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CNO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)7.36%
Div Incr Years12
Div Non Decr Years12
CNO Yearly Dividends per shareCNO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • CNO pays out 29.89% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CNO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP29.89%
EPS Next 2Y4.88%
EPS Next 3Y7.63%
CNO Yearly Income VS Free CF VS DividendCNO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M
CNO Dividend Payout.CNO Dividend Payout, showing the Payout Ratio.CNO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CNO Fundamentals: All Metrics, Ratios and Statistics

CNO FINANCIAL GROUP INC

NYSE:CNO (3/11/2026, 12:51:15 PM)

39.885

-0.73 (-1.79%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-05
Earnings (Next)04-27
Inst Owners96.34%
Inst Owner Change-0.39%
Ins Owners2.38%
Ins Owner Change5.38%
Market Cap3.76B
Revenue(TTM)4.55B
Net Income(TTM)221.50M
Analysts73.33
Price Target49.22 (23.4%)
Short Float %2.17%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield 6.41%
Yearly Dividend0.68
Dividend Growth(5Y)7.36%
DP29.89%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.96%
Min EPS beat(2)20.6%
Max EPS beat(2)39.32%
EPS beat(4)3
Avg EPS beat(4)15.15%
Min EPS beat(4)-0.86%
Max EPS beat(4)39.32%
EPS beat(8)6
Avg EPS beat(8)17.84%
EPS beat(12)8
Avg EPS beat(12)13.43%
EPS beat(16)10
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)16.87%
Min Revenue beat(2)12.84%
Max Revenue beat(2)20.9%
Revenue beat(4)4
Avg Revenue beat(4)13.04%
Min Revenue beat(4)1.91%
Max Revenue beat(4)20.9%
Revenue beat(8)8
Avg Revenue beat(8)15.09%
Revenue beat(12)12
Avg Revenue beat(12)13.84%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.12%
PT rev (3m)11.18%
EPS NQ rev (1m)2.49%
EPS NQ rev (3m)0.54%
EPS NY rev (1m)0.8%
EPS NY rev (3m)0.77%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 9.02
Fwd PE 9.03
P/S 0.83
P/FCF 5.57
P/OCF 5.57
P/B 1.43
P/tB 1.43
EV/EBITDA N/A
EPS(TTM)4.42
EY11.08%
EPS(NY)4.41
Fwd EY11.07%
FCF(TTM)7.17
FCFY17.97%
OCF(TTM)7.17
OCFY17.97%
SpS48.23
BVpS27.98
TBVpS27.98
PEG (NY)N/A
PEG (5Y)0.76
Graham Number52.75
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 8.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.55%
PM (TTM) 4.87%
GM N/A
FCFM 14.86%
ROA(3y)0.83%
ROA(5y)1.19%
ROE(3y)12.67%
ROE(5y)16.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.91%
ROCE(5y)2.08%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-13.87%
OM growth 5Y3.77%
PM growth 3Y-34%
PM growth 5Y-8.49%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.54
Debt/FCF 6
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 305.06%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)218.22%
Profit Quality(5y)167.63%
High Growth Momentum
Growth
EPS 1Y (TTM)10.78%
EPS 3Y23.97%
EPS 5Y11.8%
EPS Q2Q%12.21%
EPS Next Y-0.12%
EPS Next 2Y4.88%
EPS Next 3Y7.63%
EPS Next 5Y9.54%
Revenue 1Y (TTM)0.48%
Revenue growth 3Y8.15%
Revenue growth 5Y3.44%
Sales Q2Q%4.18%
Revenue Next Year3.65%
Revenue Next 2Y3.48%
Revenue Next 3Y3.48%
Revenue Next 5Y4.06%
EBIT growth 1Y-15.99%
EBIT growth 3Y-6.85%
EBIT growth 5Y7.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.65%
FCF growth 3Y10.9%
FCF growth 5Y-1.68%
OCF growth 1Y7.65%
OCF growth 3Y10.9%
OCF growth 5Y-1.68%

CNO FINANCIAL GROUP INC / CNO FAQ

What is the ChartMill fundamental rating of CNO FINANCIAL GROUP INC (CNO) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CNO.


What is the valuation status of CNO FINANCIAL GROUP INC (CNO) stock?

ChartMill assigns a valuation rating of 5 / 10 to CNO FINANCIAL GROUP INC (CNO). This can be considered as Fairly Valued.


How profitable is CNO FINANCIAL GROUP INC (CNO) stock?

CNO FINANCIAL GROUP INC (CNO) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CNO stock?

The Price/Earnings (PE) ratio for CNO FINANCIAL GROUP INC (CNO) is 9.02 and the Price/Book (PB) ratio is 1.43.


Is the dividend of CNO FINANCIAL GROUP INC sustainable?

The dividend rating of CNO FINANCIAL GROUP INC (CNO) is 9 / 10 and the dividend payout ratio is 29.89%.